Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 34919559.
- Also identified by DOI 10.1371/journal.pone.0261442 and PMC identifier 8682871.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A laboratory validation study was conducted to assess the equivalence of Xpert MTB/RIF Ultra testing on the GeneXpert System and the GeneXpert Omni System ('Omni') for tuberculosis and rifampicin resistance. High concordance of the two devices was demonstrated for well-characterized clinical samples as well as control materials, with controls tested on Omni at normal and challenging environmental conditions (i.e. 35°C, 90% relative humidity). Equivalence of the Cts for all probes was also shown. Equivalence was demonstrated for the Omni and GeneXpert devices for tuberculosis and rifampicin resistance detection for a diverse range of clinical specimens and environmental conditions.
Medical subject headings
- Antibiotics, Antitubercular
- Mycobacterium tuberculosis
- Point-of-Care Testing
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary